As reported by Romere et al. [7], in the state of insulin resistance, a compensatory model with a high level of asprosin and insulin was observed, but the use of specific anti-asprosin antibodies normalized the abovementioned effect. The gene discussed is FBN1; the disease is Insulin resistance.